Kent Dinucci, DPM
Foot & Ankle Surgery · Omaha, NENPI 1952363533
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (53.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Conetic Solutions, Inc. at 54.6% of the total. Reporting peaked in 2019 at $1,585 and has fallen 96.8% since, to $51 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NE, where the typical reported total is $5,810.
Across 25 payments — averaging $179.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Conetic Solutions, Inc.$2K
- Axogen$2K
- Integra Lifesciences Corporation$158
- Musculoskeletal Transplant Foundation Inc.$119
- Stryker$64
- Next Science LLC$53
- plus $33 from 1 others
What the payments were for
- Consulting fees$531%
- Travel & lodging$90320%
- Food & beverage$1,12525%
- Education$2,40054%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Conetic Solutions, Inc. | 3 | $2,448 |
| Axogen | 11 | $1,606 |
| Integra Lifesciences Corporation | 4 | $158 |
| Musculoskeletal Transplant Foundation Inc. | 2 | $119 |
| Stryker | 2 | $64 |
| Next Science LLC | 1 | $53 |
| Mimedx Group, Inc. | 2 | $33 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AxoGuard Nerve Protector$1,320
- AxoGuard Nerve Connector$1,320
- TENOGLIDE$109
How this compares
$4,481 in reported general payments places this provider in the 45th percentile of 43 foot & ankle surgery providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 16 | $354 |
| Terbinafine Hcl | 54 | $349 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $202 |
| Fluconazole | 24 | $186 |
| Cefadroxil | 20 | $168 |
| Econazole Nitrate | 16 | $132 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Omaha
- Bradley CoppleOmaha$83K
- Robert GreenhagenOmaha$29K
- Patrick NelsonOmaha$28K
- Jonathan RouseOmaha$20K
- Scott NelsonOmaha$16K
- Jordan SikesOmaha$15K
- Shannon LensingOmaha$11K
- Jorge AmaroOmaha$10K
- Kevin GrosshansOmaha$8K
- Reanen MichaelOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.